⬆ $Consun Pharmaceutical(01681)$ - Consun Pharmaceutical (1681HK)- High-Priced Acquisition & Good Performance Show Big Upside Potential. Consun achieved amazing 2021 results and is undervalued. Wanbangde’s intention to acquire Consun at high price is a catalyst. Shares have big upside potential driven by fundamentals/promising outlook. ✨ Smartkarma Access - Register your Interest (🆓)👉 Continue reading on Smartkarma (🔐)
Consun Pharmaceutical Group Ltd is a company principally engaged in manufacturing and sales of pharmaceutical products. The Company operates its businesses through two segments. Consun Pharmaceutical segment is mainly engaged in manufacturing and sells of modern Chinese medicines and medical contrast medium. Yulin Pharmaceutical segment is mainly involved in manufacturing and sells of traditional Chinese medicines. The Company's products include kidney medicines, gynaecology and paediatrics medicines, contrast medium, orthopedics medicines, dermatologic medicines, hepatobiliary medicines and others. The Company mainly operates its businesses in the domestic market.
08-26
Interim Report
INTERIM RESULTS ANNOUNCEMENTFOR THE SIX MONTHS ENDED 30 JUNE 2026